Hum. Reprod. Advance Access published online on April 21, 2007
Human Reproduction, doi:10.1093/humrep/dem096
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaginoplasty using autologous in vitro cultured vaginal tissue in a patient with Mayervon-RokitanskyKüsterHauser syndrome
1 Department of Gynaecology, Obstetrics and Perinatology, University of Rome "La Sapienza", V.le Regina Elena, 324, 00161 Rome, Italy 2 Department of Experimental Medicine, University Sapienza, V.le Regina Elena, 324, 00161 Rome, Italy
3 Correspondence address. Tel: +39-3483410486; Fax: +39-06-49972615; E-mail: pierluigi.benedettipanici{at}uniroma1.it
Mayervon-RokitanskyKüsterHauser syndrome (MRKHS) is characterized by vaginal agenesis with variable Müllerian duct abnormalities. The AbbèMcIndoe technique is considered a valid treatment option for vaginoplasty but no consensus has been reached on what material should be used for the neovagina canal wall lining. We report the first case of autologous vaginal tissue transplantation in a 28-year-old women with MRKHS. The patient was subjected to a 1 cm2 full-thickness mucosal biopsy from the vaginal vestibule. Following enzymatic dissociation, cells were inoculated onto collagen IV-coated plates and cultured for 2 weeks. The patient was subjected to a vaginoplasty with a modified AbbèMcIndoe vaginoplasty with 314 cm2 autologous in vitro cultured vaginal tissue for the canal lining. At 1 month from surgery, the vagina appeared normal in length and depth and a vaginal biopsy revealed normal vaginal tissue. The use of autologous in vitro cultured vaginal tissue to create a neovagina appears as an easy, minimally invasive and useful method.
Key words: autologous transplant/Mayervon-RokitanskyKüsterHauser syndrome/vaginoplasty
Submitted on November 9, 2006; resubmitted on January 30, 2007; accepted on February 5, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L Trommelmans, J Selling, and K Dierickx Ethical reflections on clinical trials with human tissue engineered products J. Med. Ethics, September 1, 2008; 34(9): e1 - e1. [Abstract] [Full Text] [PDF] |
||||
